How Cuozzo will impact the interplay between post grant proceedings and Hatch-Waxman litigation

Pharm Pat Anal. 2017 Jan;6(1):9-15. doi: 10.4155/ppa-2016-0041. Epub 2017 Feb 9.

Authors

Natasha Mishra^{1

2}, Patrick A Doody², Raj S Davé²

Affiliations

¹ American University, Washington College of Law, Washington, DC, USA.
² Global Pharma, Pillsbury Winthrop Shaw Pittman LLP, 1650 Tysons Boulevard, McLean, VA 22102, USA.

PMID: 28181455
DOI: 10.4155/ppa-2016-0041

No abstract available

Keywords: Cuozzo Speed Technologies; Hatch–Waxman Litigation and Inter Partes review; impact of Cuozzo on claim interpretation.

MeSH terms

Drug Approval / legislation & jurisprudence*
Drug Industry / legislation & jurisprudence*
Humans
Legislation, Drug*
Patents as Topic / legislation & jurisprudence*
United States